Arven Pharmaceuticals
Arven Pharmaceuticals develops a product portfolio covering the treatment areas of respiratory, oncology, and hematology.
Arven Pharmaceuticals is a company in biotechnology, consulting, oncology, pharmaceutical based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), Europe, Middle East, and Africa (EMEA), founded in 2013.
The company sits in the biotechnology, consulting, oncology, pharmaceutical segment, where it competes on its core product or service.
Its base of operations is Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), Europe, Middle East, and Africa (EMEA).
The company is listed at the Private company stage of development.
The company reports a headcount in the c_00251_00500 range.
| Sector | Biotechnology, Consulting, Oncology, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), Europe, Middle East, and Africa (EMEA) |
| Founded | 2013 |
| Employees | c_00251_00500 |
| Stage | Private company |
Website: arvenilac.com.tr
Browse related
Create a free account